Skip to main content

Advertisement

Log in

Diagnosis and Management of Global Development Delay: Consensus Guidelines of Growth, Development and Behavioral Pediatrics Chapter, Neurology Chapter and Neurodevelopment Pediatrics Chapter of the Indian Academy of Pediatrics

  • Guidelines
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Justification

Global developmental delay (GDD) is a relatively common neurodevelopmental disorder; however, paucity of published literature and absence of uniform guidelines increases the complexity of clinical management of this condition. Hence, there is a need of practical guidelines for the pediatrician on the diagnosis and management of GDD, summarizing the available evidence, and filling in the gaps in existing knowledge and practices.

Process

Seven subcommittees of subject experts comprising of writing and expert group from among members of Indian Academy of Pediatrics (IAP) and its chapters of Neurology, Neurodevelopment Pediatrics and Growth Development and Behavioral Pediatrics were constituted, who reviewed literature, developed key questions and prepared the first draft on guidelines after multiple rounds of discussion. The guidelines were then discussed by the whole group in an online meeting. The points of contention were discussed and a general consensus was arrived at, after which final guidelines were drafted by the writing group and approved by all contributors. The guidelines were then approved by the Executive Board of IAP.

Guidelines

GDD is defined as significant delay (at least 2 standard deviations below the mean with standardized developmental tests) in at least two developmental domains in children under 5 years of age; however, children whose delay can be explained primarily by motor issues or severe uncorrected visual/hearing impairment are excluded. Severity of GDD can be classified as mild, moderate, severe and profound on adaptive functioning. For all children, in addition to routine surveillance, developmental screening using standardized tools should be done at 9–12 months, 18–24 months, and at school entry; whereas, for high risk infants, it should be done 6-monthly till 24 months and yearly till 5 years of age; in addition to once at school entry. All children, especially those diagnosed with GDD, should be screened for ASD at 18–24 months, and if screen negative, again at 3 years of age. It is recommended that investigations should always follow a careful history and examination to plan targeted testing and, vision and hearing screening should be done in all cases prior to standardized tests of development. Neuroimaging, preferably magnetic resonance imaging of the brain, should be obtained when specific clinical indicators are present. Biochemical and metabolic investigations should be targeted towards identifying treatable conditions and genetic tests are recommended in presence of clinical suspicion of a genetic syndrome and/or in the absence of a clear etiology. Multidisciplinary intervention should be initiated soon after the delay is recognized even before a formal diagnosis is made, and early intervention for high risk infants should start in the nursery with developmentally supportive care. Detailed structured counselling of family regarding the diagnosis, etiology, comorbidities, investigations, management, prognosis and follow-up is recommended. Regular targeted follow-up should be done, preferably in consultation with a team of experts led by a developmental pediatrician/pediatric neurologist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shevell M, Ashwal S, Donley D, et al. Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice Parameter: Evaluation of the child with Global Developmental Delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60:367–80.

    Article  CAS  PubMed  Google Scholar 

  2. Demirci A, Kartal M. The prevalence of developmental delay among children aged 3–60 months in Izmir, Turkey. Child Care Health Dev. 2016 42:213–9.

    Article  CAS  PubMed  Google Scholar 

  3. Eapen V, Zoubeidi T, Yunis F, et al. Prevalence and psychosocial correlates of global developmental delay in 3-year-old children in the United Arab Emirates. J Psychosom Res. 2006; 61:321–6.

    Article  PubMed  Google Scholar 

  4. Sharma N, Masood J, Singh SN, et al. Assessment of risk factors for developmental delays among children in a rural community of North India: A cross-sectional study. J Educ Health Promot. 2019;8:112.

    PubMed  PubMed Central  Google Scholar 

  5. Agarwal D, Chaudhary SS, Sachdeva S, et al. Prevalence of developmental delay and factors affecting the development status among under 5 children in an urban slum of Agra City. Natl J Community Med. 2018;9: 474–79.

    Google Scholar 

  6. Kishore MT, Udipi GA, Seshadri SP. Clinical Practice Guidelines for Assessment and Management of intellectual disability. Indian J Psychiatry. 2019;61:194–210.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Srour M, Shevell M. Genetics and the investigation of developmental delay/intellectual disability. Arch Dis Child. 2014;99:386–9.

    Article  PubMed  Google Scholar 

  8. Jimenez-Gomez A, Standridge SM. A refined approach to evaluating global developmental delay for the international medical community. Pediatr Neurol. 2014;51:198–206.

    Article  PubMed  Google Scholar 

  9. Wilska ML, Kaski MK. Why and how to assess the aetiological diagnosis of children with intellectual disability/mental retardation and other neurodevelopmental disorders: description of the Finnish approach. Eur J Paediatr Neurol. 2001;5:7–13.

    Article  CAS  PubMed  Google Scholar 

  10. Jain S, Chowdhury V, Juneja M, et al. Intellectual disability in Indian children: Experience with a stratified approach for etiological diagnosis. Indian Pediatr. 2013; 50: 1125–130.

    Article  PubMed  Google Scholar 

  11. Tikaria A, Kabra M, Gupta N, et al. Etiology of global developmental delay in young children: Experience from a tertiary care centre in India. Natl Med J India. 2010;23:324–9.

    PubMed  Google Scholar 

  12. Ali YF, El-Morshedy S, Elsayed RM, et al. Metabolic screening and its impact in children with nonsyndromic intellectual disability. Neuropsychiatr Dis Treat. 2017;13:1065–70.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Jauhari P, Boggula R, Bhave A, et al. Etiology of intellectual disability in pediatric outpatients in Northern India. Dev Med Child Neurol. 2011;53:167–72.

    Article  PubMed  Google Scholar 

  14. Majnemer A, Shevell MI. Diagnostic yield of the neurologic assessment of the developmentally delayed child. J Pediatr. 1995; 127:193–9.

    Article  CAS  PubMed  Google Scholar 

  15. Gupta N, Kabra M. Approach to the diagnosis of develop-mental delay - the changing scenario. Indian J Med Res. 2014; 139:4–6.

    PubMed  PubMed Central  Google Scholar 

  16. López-Pisón J, García-Jiménez MC, Monge-Galindo L, et al. Our experience with the aetiological diagnosis of global developmental delay and intellectual disability: 2006–2010. Neuro-logia. 2014;29:402–7.

    Google Scholar 

  17. Srour M, Mazer B, Shevell MI. Analysis of clinical features predicting etiologic yield in the assessment of global developmental delay. Pediatrics. 2006;118:139–45.

    Article  PubMed  Google Scholar 

  18. Ozmen M, Tatli B, Aydinli N, et al. Etiologic evaluation in 247 children with global developmental delay at Istanbul, Turkey. J Trop Pediatr. 2005;51:310–3.

    Article  PubMed  Google Scholar 

  19. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of subspecialists’ evaluation of young children with global developmental delay. J Pediatr. 2000;136:593–8.

    Article  CAS  PubMed  Google Scholar 

  20. Jauhari P, Bhargava R, Bhave A, et al. Comorbidities associated with intellectual disability among pediatric outpatients seen at a teaching hospital in Northern India. J Policy Pract Intellect Disabil. 2012; 9:10–16.

    Article  Google Scholar 

  21. Einfeld SL, Ellis LA, Emerson E. Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Develop Disab. 2011;36:137–43.

    Article  Google Scholar 

  22. Hegde V, Jain R, Bappal A, Shambhu R. Ocular manifestations in children with developmental delay at a tertiary center in South India. Saudi J Ophthalmol. 2021;35:1–4.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Shabnam S, Ravi SK, Swapna N. Feeding and swallowing issues in children with neuro-developmental disorders. In: Gupta S, Venkatesan S, Goswami S.P, editors. Emerging Trends in the Diagnosis and Intervention of Neurodevelopmental Disorders. 1st ed. IGI Global; 2019.p.56–75.

  24. Wiggs L. Sleep problems in children with developmental dis-orders. J R Soc Med. 2001;94:177–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. American Psychiatric Association. Intellectual Development Disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; 2013.p.33–41.

  26. Desmond P. Kelly MJN. Neurodevelopment and Executive function and dysfunction. In: M. Kliegman, Richard E. Behrman HBJ editors. Nelson Textbook of Pediatrics. 21st ed. Elsevier Inc;2020. p.1690–91.

  27. Nelson CA 3rd, Zeanah CH, Fox NA, et al. Cognitive recovery in socially deprived young children: The Bucharest Early Intervention Project. Science. 2007;318:1937–40.

    Article  CAS  PubMed  Google Scholar 

  28. Andrew A, Attanasio O, Augsburg B, et al. Effects of a scalable home-visiting intervention on child development in slums of urban India: Evidence from a randomised controlled trial. J Child Psychol Psychiatry. 2020;61:644–52.

    Article  PubMed  Google Scholar 

  29. Gazette of India (Extra-Ordinary). The Rights of Persons with Disabilities Act, 2016. Accessed on Nov 27, 2021. Available from: http://www.disabilityaffairs.gov.in/uploaad/uploadfiles/files/RPWD/ACT/2016.pdf

  30. Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying Infants and Young Children With Developmental Disorders in the Medical Home:An Algorithm for Developmental Surveillance and Screening. Pediatrics. 2006;118:405–20.

    Article  Google Scholar 

  31. Scharf RJ, Scharf GJ, Stroustrup A. Developmental Milestones. Pediatr Rev. 2016;37:25–37.

    Article  PubMed  Google Scholar 

  32. Nair MK, Nair GS, George B, et al. Development and validation of Trivandrum Development Screening Chart for children aged 0–6 years [TDSC (0-6)]. Indian J Pediatr. 2013;80:S248–55.

    Article  PubMed  Google Scholar 

  33. Glascoe FP, Byrne KE, Ashford LG, et al. Accuracy of the Denver-II in developmental screening. Pediatrics. 1992;89: 1221–5.

    Article  CAS  PubMed  Google Scholar 

  34. Bal R, Karyakram S. Child Health Screening and Early Intervention Services. National Rural Health Mission, 2014. Accessed November 15, 2021. Available from: https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/RBSK_Job_Aids.pdf

  35. Phatak AT, Khurana B. Baroda development screening test for infants. Indian Pediatr. 1991;28:31–7.

    CAS  PubMed  Google Scholar 

  36. Alpern Gerald, Boll Thomas, Shearer Marsha S. Developmental Profile II (DP-II) Manual. 2nd ed. Western Psychological Services, 1994.

  37. Kamat V. A revision of the Binet scale for Indian children (Kanarese and Marathi speaking). British Journal of Edu-cational Psychology. 2011;4:296–309.

    Article  Google Scholar 

  38. Sparrow S, Ciccheti V, Saulnier A. Vineland Adaptive Behaviour Scales (VABS). 3rd ed. Pearson, 2016.

  39. Bharat Raj. Vineland Social Maturity Scale and Manual, Indian Adaptation-Enlarged Version, Swayamsiddha-Prakashanam 1992

  40. Pathak P. Developmental assessment scales for Indian infants (DASII). Anand Agencies; 1998.

  41. Albers, C. A., and Grieve, A. J. (2007). Bayley, N. (2006). Bayley Scales of Infant and Toddler Development, 3rd ed. Harcourt Assessment. P.180–190.

  42. Shank L. Mullen Scales of Early Learning. In: Kreutzer JS, DeLuca J, Caplan B. (eds) Encyclopedia of Clinical Neuro-psychology. Springer. 2011. Available on https://doi.org/10.1007/978-0-387-79948-3_1570

  43. Griffiths R. The abilities of young children: A comprehensive system of mental measurement for the first eight years of life. Association for Research in Infant and Child Development; 1984. p.101–172.

  44. Gesell Institute of Child Development. Gesell develop- mental observation-revised and Gesell early screener technical report ages 3–6. 2012.Available from http://www.gesellinstitute.org

  45. Eiserman WD, Shisler L, Foust T. Hearing Screening in Early Childcare Settings. ASHA Lead 2008; 13: 34–37. Available at https://www.infanthearing.org/earlychildhood/docs/ASHA%20Leader%20article.pdf

  46. Chang MY, Borchert MS. Advances in the evaluation and management of cortical/cerebral visual impairment in children. Surv Ophthalmol. 2020;65:708–24.

    Article  PubMed  Google Scholar 

  47. Ganesan S, Thanawala N, Hussain N. Vitamin B12 deficiency: a treatable cause of developmental delay in infancy. J Paediatr Child Health. 2013;49:E348–9.

    Article  PubMed  Google Scholar 

  48. McDonald L, Rennie A, Tolmie J, et al. Investigation of global developmental delay. Arch Dis Child. 2006;91:701–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Mithyantha R, Kneen R, McCann E, Gladstone M. Current evidence-based recommendations on investigating children with global developmental delay. Arch Dis Child. 2017;102: 1071–76.

    Article  PubMed  Google Scholar 

  50. Hsu, RH, Chien, YH., Hwu, WL. et al. Genotypic and phenotypic correlations of biotinidase deficiency in the Chinese population. Orphanet J Rare Dis. 2019;14:6.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Bélanger SA, Caron J. Evaluation of the child with global developmental delay and intellectual disability. Paediatr Child Health. 2018;23:403–19.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Moeschler JB, Shevell M. Committee on Genetics. Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental Delays. Pediatrics. 2014;134:e903–18.

    Article  PubMed  Google Scholar 

  53. Griffiths PD, Batty R, Warren D, et al. The use of MR imaging and spectroscopy of the brain in children investigated for developmental delay: what is the most appropriate imaging strategy? Eur Radiol. 2011;21:1820–30.

    Article  PubMed  Google Scholar 

  54. Cleary MA, Green A. Developmental delay: when to suspect and how to investigate for an inborn error of metabolism. Arch Dis Child. 2005;90:1128–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Shaffer, Lisa. American College of Medical Genetics Guideline on the Cytogenetic Evaluation of the Individual With Developmental Delay or Mental Retardation. Genet Med. 2005;7:650–54.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Kharbanda M, Tolmie J, Joss S. How to use … microarray comparative genomic hybridisation to investigate developmental disorders. Arch Dis Child Educ Pract Ed. 2015;100:24–9.

    Article  PubMed  Google Scholar 

  57. Savatt JM, Myers SM. Genetic Testing in Neurodevelopmental Disorders. Front Pediatr. 2021;9:526779.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Millichap J, Millichap John. AAP Genetics. Diagnostic approach to intellectual disability or global developmental delay. Pediatric Neurology Briefs. 2014;79.

  59. Altimier L, Phillips R. The Neonatal Integrative Developmental Care Model: Advanced Clinical Applications of the Seven Core Measures for Neuroprotective Family-centered Developmental Care. Newborn Infant Nurs Rev. 2016;16:230–44.

    Article  Google Scholar 

  60. Coughlin M, Gibbins S, Hoath S. Core measures for developmentally supportive care in neonatal intensive care units: theory, precedence and practice. J Adv Nurs. 2009; 65:2239–48.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Eva MM. Hoytema van Konijnenburg, Saskia B. Wortmann, Marina Johanna Koelewijn et al. Treatable Inherited Metabolic Disorders Causing Intellectual Disability: 2020 Review And Diagnostic App. Orphanet J Rare Dis. 2021;16:170. Available as Treatable-ID App on https://www.treatable-id.org/about.html

    Google Scholar 

  62. Van Karnebeek CD, Houben RF, Lafek M, et al. The treatable intellectual disability APP www.treatable-id.org: A digital tool to enhance diagnosis and care for rare diseases. Orphanet J Rare Dis. 2012;7:47.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Bharadva K, Shastri D, Gaonkar N, et al. Consensus Statement of Indian Academy of Pediatrics on Early Childhood Develop-ment. Indian Pediatr. 2020;57:834–41.

    Article  PubMed  Google Scholar 

  64. Chandrasekhar P, Ramachandran S. Growth charts for Indian boys (0-36 months) with down’s syndrome: a pilot study. Int J Contemp Pediatr. 2018;5:2156.

    Article  Google Scholar 

  65. Chandrasekhar P, Ramchandran S. Growth chart of Indian girls with Down syndrome from birth to three years-a pilot study. J Down Syndr Chr Abnorm. 2018;4:2.

    Google Scholar 

  66. Butler MG, Lee J, Manzardo AM, et al. Growth charts for non-growth hormone treated Prader-Willi syndrome. Pediatrics. 2015;135:e126–35. Erratum in: Pediatrics. 2015;135:946.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Hwang AW, Chao MY, Liu SW. A randomized controlled trial of routines-based early intervention for children with or at risk for developmental delay. Res Dev Disabil. 2013;34:3112–23.

    Article  PubMed  Google Scholar 

  68. Cameron RJ. Early intervention for young children with developmental delay: the Portage approach. Child Care Health Dev. 1997;23:11–27.

    Article  CAS  PubMed  Google Scholar 

  69. Ministry of health and family welfare ministry of women and child development mother-child protection card 2018. Accessed November 21, 2021. Available at https://nhm.gov.in/New_Updates_2018/NHM_Components/Immunization/Guildelines_for_immunization/MCP_Guide_Book.pdf

  70. Baker BL, Blacher J, Crnic KA, Edelbrock C. Behavior prob-lems and parenting stress in families of three-year-old children with and without developmental delays. Am J Ment Retard. 2002;107:433–44.

    Article  PubMed  Google Scholar 

  71. Eisenhower AS, Baker BL, Blacher J. Preschool children with intellectual disability: syndrome specificity, behaviour problems, and maternal well-being. J Intellect Disabil Res. 2005; 49:657–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Gadow KD, Sprafkin J, Nolan EE. DSM-IV symptoms in community and clinic preschool children. J Am Acad Child Adolesc Psychiatry. 2001;40:1383–92.

    Article  CAS  PubMed  Google Scholar 

  73. Hasnat MJ, Graves P. Disclosure of developmental disability: A study of parent satisfaction and the determinants of satisfaction. J Paediatr Child Health. 2000;36:32–5.

    Article  CAS  PubMed  Google Scholar 

  74. Tsai JD, Mou CH, Chang HY, et al. Trend of subsequent epilepsy in children with recurrent febrile seizures: A retrospective matched cohort study. Seizure. 2018;61:164–69.

    Article  PubMed  Google Scholar 

  75. Hofert SM, Burke MG. Nothing is simple about a complex febrile seizure: looking beyond fever as a cause for seizures in children. Hosp Pediatr. 2014;4:181–7.

    Article  PubMed  Google Scholar 

  76. Patel AD, Vidaurre J. Complex febrile seizures: A practical guide to evaluation and treatment. J Child Neurol. 2013;28: 762–7.

    Article  PubMed  Google Scholar 

  77. Pavlidou E, Tzitiridou M, Kontopoulos E, Panteliadis CP. Which factors determine febrile seizure recurrence? A prospective study. Brain Dev. 2008;30:7–13.

    Article  PubMed  Google Scholar 

  78. Canpolat M, Per H, Gumus H, et al. Investigating the pre-valence of febrile convulsion in Kayseri, Turkey: An assess-ment of the risk factors for recurrence of febrile convulsion and for development of epilepsy. Seizure. 2018;55:36–47.

    Article  PubMed  Google Scholar 

  79. Natsume J, Hamano SI, Iyoda K, et al. New guidelines for management of febrile seizures in Japan. Brain Dev. 2017;39:2–9.

    Article  PubMed  Google Scholar 

  80. Salt A, Sargent J. Common visual problems in children with disability. Arch Dis Child. 2014;99:1163–8.

    Article  PubMed  Google Scholar 

  81. Akinci A, Oner O, Bozkurt OH, et al. Refractive errors and ocular findings in children with intellectual disability: a controlled study. J AAPOS. 2008;12:477–81.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Smitha K, Patil V, Kamate M, et al. Impact of refractive error correction on mental and visual development in children with global developmental delay. Indian J Heal Sci Biomed Res. 2019;12:117.

    Article  Google Scholar 

  83. Cohen-Maitre SA, Haerich P. Visual attention to movement and color in children with cortical visual impairment. J Vis Impair Blind. 2005;99:389–402.

    Article  Google Scholar 

  84. Meinzen-Derr J, Wiley S, Grether S, Choo DI. Children with cochlear implants and developmental disabilities: A language skills study with developmentally matched hearing peers. Res Dev Disabil. 2011;32:757–67.

    Article  PubMed  Google Scholar 

  85. Jan JE, Owens JA, Weiss MD, et al. Sleep hygiene for children with neurodevelopmental disabilities. Pediatrics. 2008;122: 1343–50.

    Article  PubMed  Google Scholar 

  86. Patel DR, Neelakantan M, Pandher K, Merrick J. Cerebral palsy in children: a clinical overview. Transl Pediatr. 2020;9: S125–S135.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Sloper P, Turner S. Determinants of parental satisfaction with disclosure of disability. Dev Med Child Neurol. 1993;35:816–25.

    Article  CAS  PubMed  Google Scholar 

  88. Svarstad BL, Lipton HL. Informing parents about mental retardation: a study of professional communication and parent acceptance. Soc Sci Med. 1977;11:645–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Funding: None; Competing interests: None stated.

Author information

Authors and Affiliations

Authors

Contributions

All authors have contributed to the initial draft of the manuscript, made important intellectual contribution in the framing of the guidelines and finalization of the manuscript, and approved the final manuscript.

Corresponding author

Correspondence to Monica Juneja.

Additional information

Note

Additional material related to this study is available with the online version at www.indianpediatrics.net

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Juneja, M., Gupta, A., Sairam, S. et al. Diagnosis and Management of Global Development Delay: Consensus Guidelines of Growth, Development and Behavioral Pediatrics Chapter, Neurology Chapter and Neurodevelopment Pediatrics Chapter of the Indian Academy of Pediatrics. Indian Pediatr 59, 401–415 (2022). https://doi.org/10.1007/s13312-022-2522-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-022-2522-5

Keywords

Navigation